2 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Thromboembolism: new trials by email Literature Review of Thromboembolism trials Research Report on Thromboembolism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms Palbociclib, Rivaroxaban, SNP - Cancer, Solid Tumor | Phase 1 | Unknown | Lebanese University | 500 | 2019-02-01 | 2023-10-06 |
| Efficacy Comparison of Warfarin Versus Rivaroxaban CVT Rivaroxaban, Warfarin - Cerebral Venous Thrombosis | Phase 1 / Phase 2 | Unknown | Isfahan University of Medical Sciences | 50 | 2018-09-01 | 2018-11-20 |
Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Cardiovascular Diseases (1) · Colonic Neoplasms (1) · Immune System Diseases (1) · Inflammation (1) · Intracranial Thrombosis (1) · Lung Neoplasms (1) · Neoplasms (1) · Prostatic Neoplasms (1) · Thrombosis (1)
Embolism and Thrombosis (2) · Vascular Diseases (2) · Adenocarcinoma (1) · Brain Diseases (1) · Breast Diseases (1) · Carcinoma (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Colonic Diseases (1) · Colorectal Neoplasms (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1)
Rivaroxaban (2) · Warfarin (1) · palbociclib (1)
Isfahan University of Medical Sciences (1) · Lebanese University (1)
Iran (1) · Lebanon (1)
Mohammad Saadatnia, Prof (1) · Nehman Makdissy, Professor (1)